DIAdvisor

The DIAdvisor is a large scale- integrating project (IP) aiming at development of a prediction based tool which uses past and easily available information to optimise the therapy of type I and developed type II diabetes.

The DIAdvisor does not depend on specific sensor technologies and technologies like standard strip sensing, minimally invasive continuous glucose sensors and non-invasive methods.

For safety reason, the DIAdvisor system will be able to self-assess the confidence of its proposed decisions. For safety reasons as well as for the sake of therapy improvements the system connects and provides information and trends to the Health Care Provider.

Glucose prediction is difficult and requires advanced science. This can be achieved only by a well-balanced group of eminent experts including academics, clinicians, user representatives and leading companies. This includes physiological modelling, identification theory, control theory, medical device technology, risk management theory, sensor science and user understanding.

The expected impact of DIAdvisor will be improved diabetes control and quality of life in large populations of insulin treated patients, leading to fewer diabetic complications and lower Health Care costs. Moreover, the project will constitute a valuable opportunity for European companies to build up a special know-how leading products that profoundly and positively impacts the lives of millions with other indications than diabetes.

For further information, please visit:
http://www.diadvisor.eu/

Project co-ordinator:
Novo Nordisk A/S (Denmark)

Partners:

  • Novo Nordisk A/S (Denmark),
  • Johannes Kepler Universität Linz (Austria),
  • Lunds Universitet (Sweden),
  • Universita Degli Studi di Padova (Italy),
  • Centre Hospitalier Regional Universitaire de Montpellier (France),
  • Toumaz Technology Ltd (UK),
  • Sensor Technology and Devices Ltd (UK),
  • Ondalys SARL (France),
  • Romsoft SRL (Romania),
  • Institut Klinicke a Experimentalni Mediciny (Czech Republic),
  • RICAM, Österreichische Akademie der Wissenschaften (Austria),
  • Rambøll Danmark A/S (Denmark),
  • Federation Internationale du Diabete Region Europe (Belgium)

Timetable: from 03/2008 – to 02/2012

Total cost: € 9.284.061

EC funding: € 7.099.992

Programme Acronym: FP7-ICT

Subprogramme Area: Personal health systems for monitoring and point-of-care diagnostics

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

Leading Health Systems Sign On to Delive…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the expanding adoption of its Population Health Management solutions with health systems across the globe, including...

Pflegetiger Adds Digital Health Ventures…

Since summer 2016, Pflegetiger has been developing its innovative concept of neighborhood care, a concept designed to make in-home care attractive for care professionals again. The company's revolutionary approach -...

Can Virtual Reality be Used to Manage Pa…

Virtual reality has emerged into popular culture with an ever-widening array of applications including clinical use in a pediatric healthcare center. Children undergo necessary yet painful and distressing medical procedures...

Free iPhone App could Guide MS Research…

For some diseases, a simple blood test is all that's needed to estimate severity or confirm a diagnosis. Not so for multiple sclerosis. No single lab test can tell doctors...

Using Social Media Big Data to Combat Pr…

Researchers at Dartmouth, Stanford University, and IBM Research, conducted a critical review of existing literature to determine whether social media big data can be used to understand communication and behavioral...

B.Braun Accelerator Call for Innovative …

B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. The company employs more than 60,000 employees in 64 countries and is looking for European...

'NHS Cyber Security Batsignal' Peer-to-P…

The two chairs of the largest independent communities of NHS digital leaders will launch the 'NHS Cyber Security Batsignal', a new peer-to-peer cyber security warning alerting system, at the first...

Giving Rookie Dads the Online Info they …

Expectant and new parents often turn to the internet for parenting prep, but it turns out that dads often don't seem to find the information they say they need about...

Artificial Intelligence to Evaluate Brai…

Researchers at the University of Helsinki and the Helsinki University Hospital (HUH), Finland, have developed software based on machine learning, which can independently interpret EEG signals from a premature infant...

FDA Approves Pill with Sensor that Digit…

The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor...

Philips Partners with Dutch Health Insur…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is collaborating with Dutch health insurer ONVZ to provide an industry first, strategic cooperation...